PMID: 28751571

In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing.

Arteriosclerosis, thrombosis, and vascular biology
AC Chadwick, X Wang, K Musunuru
2017-09

1 variant was identified in this publication


Variant ID Gene cDNA Protein Consequence Exon Intron
1-55521770-C-T PCSK9 c.904C>T p.Gln302* Nonsense 6/12 -